Holders over time
- HCAT
- SPCX
| Quarter | HCAT | SPCX |
|---|---|---|
| Q4 2019 | 3 holders, $8.6m | none listed holders, n.a. |
| Q1 2020 | 6 holders, $55m | none listed holders, n.a. |
| Q2 2020 | 6 holders, $104m | none listed holders, n.a. |
| Q3 2020 | 7 holders, $231m | none listed holders, n.a. |
| Q4 2020 | 10 holders, $329m | none listed holders, n.a. |
| Q1 2021 | 8 holders, $342m | none listed holders, n.a. |
| Q2 2021 | 13 holders, $409m | none listed holders, n.a. |
| Q3 2021 | 10 holders, $374m | none listed holders, n.a. |
| Q4 2021 | 6 holders, $280m | none listed holders, n.a. |
| Q1 2022 | 3 holders, $200m | none listed holders, n.a. |
| Q2 2022 | 4 holders, $93m | none listed holders, n.a. |
| Q3 2022 | 7 holders, $35m | none listed holders, n.a. |
| Q4 2022 | 5 holders, $31m | none listed holders, n.a. |
| Q1 2023 | 4 holders, $31m | none listed holders, n.a. |
| Q2 2023 | 3 holders, $38m | none listed holders, n.a. |
| Q3 2023 | 2 holders, $45m | none listed holders, n.a. |
| Q4 2023 | 3 holders, $48m | none listed holders, n.a. |
| Q1 2024 | 2 holders, $9.5m | none listed holders, n.a. |
| Q2 2024 | 1 holders, $2.8m | none listed holders, n.a. |
| Q3 2024 | 1 holders, $992k | none listed holders, n.a. |
| Q1 2025 | 1 holders, $989k | none listed holders, n.a. |
| Q2 2025 | 1 holders, $652k | none listed holders, n.a. |
| Q3 2025 | 1 holders, $1.1m | none listed holders, n.a. |
| Q2 2026 | none listed holders, n.a. | 42 holders, $105bn |
Health Catalyst Inc
- Holders
- 0
- Reported value
- $0
- Buyers
- 11
- Sellers
- 4
Breadth +7 among 91 comparable managers.
- Holders
- 42
- Reported value
- $105bn
- Buyers
- 51
- Sellers
- 0
Not ranked this quarter: its new positions are allocations in a new listing.
Who holds both, Q2 2026
Both (0)
No tracked manager lists every one of them.
Only HCAT (0)
None.
Only SPCX (42)
AllianceBernstein LP, Altimeter Capital Management LP, Appaloosa LP, ARK Investment Management LLC, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., D1 Capital Partners LP, Davidson Kempner Capital Management LP, Dragoneer Investment Group LLC, Element Capital Management LLC, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Freestone Grove Partners LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, MFS Investment Management, Millennium Management LLC, and 17 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.